Millar Thomas J, Mudgil Poonam, Butovich Igor A, Palaniappan Chendur K
School of Natural Sciences, Parramatta Campus, University of Western Sydney, Sydney, New South Wales, Australia.
Invest Ophthalmol Vis Sci. 2009 Jan;50(1):140-51. doi: 10.1167/iovs.08-2097. Epub 2008 Aug 29.
Tear lipocalin (Tlc) is a major lipid binding protein in tears and is thought to have an important role in stabilizing the Meibomian lipid layer by transferring lipids to it from the aqueous layer or ocular surface, or by adsorbing to it directly. These possible roles have been investigated in vitro using human Tlc.
Tlc was purified from human tears by size exclusion chromatography followed by ion exchange chromatography. Three additional samples of the Tlc were prepared by lipidation, delipidation, and relipidation. The lipids extracted from the purified Tlc were analyzed by HPLC-MS followed by fragmentation. Adsorption of these different forms of Tlc to a human Meibomian lipid film spread on the surface of an artificial tear buffer in a Langmuir trough were observed by recording changes in the pressure with time (Pi-T profile) and monitoring the appearance of the film microscopically. These results were compared with similar experiments using a bovine Meibomian lipid film.
The results indicated that Tlc binds slowly to a human Meibomian lipid film compared with lysozyme or lactoferrin, even at 37 degrees C. The adsorption of Tlc to a human Meibomian lipid film was very different from its adsorption to a bovine Meibomian lipid film, indicating the nature of the lipids in the film is critical to the adsorption process. Similarly, the different forms of Tlc had quite distinct adsorption patterns, as indicated both by changes in Pi-T profiles and the microscopic appearance of the films.
It was concluded that human Tlc was capable of adsorbing to and penetrating into a Meibomian lipid layer, but this process is very complex and depends on both the types of lipids bound to Tlc and the lipid complement comprising the Meibomian lipid film.
泪液脂质运载蛋白(Tlc)是泪液中的一种主要脂质结合蛋白,被认为在通过将脂质从水层或眼表转移至睑板脂质层,或直接吸附于睑板脂质层来稳定睑板脂质层方面发挥重要作用。已使用人Tlc在体外对这些可能的作用进行了研究。
通过尺寸排阻色谱法继以离子交换色谱法从人泪液中纯化Tlc。通过脂质化、去脂质化和再脂质化制备另外三个Tlc样品。从纯化的Tlc中提取的脂质通过高效液相色谱-质谱联用仪继以碎片分析进行分析。通过记录压力随时间的变化(Pi-T曲线)并在显微镜下监测膜的外观,观察这些不同形式的Tlc对铺展在人工泪液缓冲液表面的人睑板脂质膜在Langmuir槽中的吸附情况。将这些结果与使用牛睑板脂质膜的类似实验进行比较。
结果表明,即使在37℃时,与溶菌酶或乳铁蛋白相比,Tlc与人睑板脂质膜的结合也较慢。Tlc对人睑板脂质膜的吸附与其对牛睑板脂质膜的吸附非常不同,表明膜中脂质的性质对吸附过程至关重要。同样,不同形式的Tlc具有相当不同的吸附模式,这在Pi-T曲线的变化和膜的显微镜外观中均有体现。
得出的结论是,人Tlc能够吸附并渗透到睑板脂质层中,但这个过程非常复杂,并且取决于与Tlc结合的脂质类型以及构成睑板脂质膜的脂质组成。